Annual EBIT:
-$501.88M-$305.18M(-155.15%)Summary
- As of today, DNLI annual earnings before interest & taxes is -$501.88 million, with the most recent change of -$305.18 million (-155.15%) on December 31, 2024.
- During the last 3 years, DNLI annual EBIT has fallen by -$206.13 million (-69.70%).
- DNLI annual EBIT is now -900.21% below its all-time high of $62.72 million, reached on December 31, 2020.
Performance
DNLI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$134.96M+$10.62M(+7.29%)Summary
- As of today, DNLI quarterly earnings before interest & taxes is -$134.96 million, with the most recent change of +$10.62 million (+7.29%) on June 30, 2025.
- Over the past year, DNLI quarterly EBIT has dropped by -$18.37 million (-15.76%).
- DNLI quarterly EBIT is now -155.30% below its all-time high of $244.08 million, reached on December 31, 2020.
Performance
DNLI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$533.58M-$18.37M(-3.57%)Summary
- As of today, DNLI TTM earnings before interest & taxes is -$533.58 million, with the most recent change of -$18.37 million (-3.57%) on June 30, 2025.
- Over the past year, DNLI TTM EBIT has dropped by -$38.36 million (-7.75%).
- DNLI TTM EBIT is now -950.75% below its all-time high of $62.72 million, reached on December 31, 2020.
Performance
DNLI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DNLI EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -155.2% | -15.8% | -7.8% |
| 3Y3 Years | -69.7% | -119.8% | -83.6% |
| 5Y5 Years | -135.4% | -120.3% | -123.1% |
DNLI EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -155.2% | at low | -179.2% | +7.3% | -227.0% | at low |
| 5Y | 5-Year | -900.2% | at low | -155.3% | +7.3% | -950.8% | at low |
| All-Time | All-Time | -900.2% | at low | -155.3% | +7.3% | -950.8% | at low |
DNLI EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$134.96M(+7.3%) | -$533.58M(-3.6%) |
| Mar 2025 | - | -$145.58M(-12.1%) | -$515.21M(-2.7%) |
| Dec 2024 | -$501.88M(-155.2%) | -$129.85M(-5.4%) | -$501.88M(+0.5%) |
| Sep 2024 | - | -$123.19M(-5.7%) | -$504.60M(-1.9%) |
| Jun 2024 | - | -$116.59M(+11.8%) | -$495.21M(-137.9%) |
| Mar 2024 | - | -$132.25M(+0.2%) | -$208.14M(-5.8%) |
| Dec 2023 | -$196.70M(+42.3%) | -$132.57M(-16.5%) | -$196.70M(-16.1%) |
| Sep 2023 | - | -$113.80M(-166.7%) | -$169.47M(-3.9%) |
| Jun 2023 | - | $170.48M(+241.1%) | -$163.16M(+58.7%) |
| Mar 2023 | - | -$120.81M(-14.7%) | -$395.06M(-15.9%) |
| Dec 2022 | -$340.74M(-15.2%) | -$105.34M(+2.0%) | -$340.74M(-9.0%) |
| Sep 2022 | - | -$107.49M(-75.0%) | -$312.52M(-7.5%) |
| Jun 2022 | - | -$61.42M(+7.6%) | -$290.63M(+0.1%) |
| Mar 2022 | - | -$66.50M(+13.8%) | -$291.03M(+1.6%) |
| Dec 2021 | -$295.75M(-571.6%) | -$77.12M(+9.9%) | -$295.75M(-1262.2%) |
| Sep 2021 | - | -$85.59M(-38.5%) | $25.45M(-50.0%) |
| Jun 2021 | - | -$61.82M(+13.2%) | $50.92M(-1.0%) |
| Mar 2021 | - | -$71.22M(-129.2%) | $51.47M(-17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $62.72M(+129.4%) | $244.08M(+506.0%) | $62.72M(+126.2%) |
| Sep 2020 | - | -$60.12M(+1.9%) | -$239.12M(-4.3%) |
| Jun 2020 | - | -$61.28M(-2.2%) | -$229.16M(-0.1%) |
| Mar 2020 | - | -$59.97M(-3.8%) | -$228.84M(-8.3%) |
| Dec 2019 | -$213.18M(-359.7%) | -$57.76M(-15.2%) | -$211.38M(-167.9%) |
| Sep 2019 | - | -$50.16M(+17.7%) | -$78.90M(-18.3%) |
| Jun 2019 | - | -$60.96M(-43.4%) | -$66.71M(-20.8%) |
| Mar 2019 | - | -$42.51M(-156.9%) | -$55.23M(-43.6%) |
| Dec 2018 | -$46.37M(+48.6%) | $74.72M(+296.8%) | -$38.47M(+71.9%) |
| Sep 2018 | - | -$37.96M(+23.3%) | -$136.73M(-12.9%) |
| Jun 2018 | - | -$49.48M(-92.2%) | -$121.06M(-28.6%) |
| Mar 2018 | - | -$25.75M(-9.4%) | -$94.14M(-4.4%) |
| Dec 2017 | -$90.14M(-3.1%) | -$23.54M(-5.6%) | -$90.14M(-4.4%) |
| Sep 2017 | - | -$22.29M(+1.2%) | -$86.38M(+9.1%) |
| Jun 2017 | - | -$22.57M(-3.8%) | -$95.02M(-31.1%) |
| Mar 2017 | - | -$21.74M(-10.0%) | -$72.45M(-42.9%) |
| Dec 2016 | -$87.43M(-424.2%) | -$19.78M(+36.1%) | -$50.71M(-63.9%) |
| Sep 2016 | - | -$30.93M | -$30.93M |
| Dec 2015 | -$16.68M | - | - |
FAQ
- What is Denali Therapeutics Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual EBIT year-on-year change?
- What is Denali Therapeutics Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly EBIT year-on-year change?
- What is Denali Therapeutics Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. TTM EBIT year-on-year change?
What is Denali Therapeutics Inc. annual earnings before interest & taxes?
The current annual EBIT of DNLI is -$501.88M
What is the all-time high annual EBIT for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual earnings before interest & taxes is $62.72M
What is Denali Therapeutics Inc. annual EBIT year-on-year change?
Over the past year, DNLI annual earnings before interest & taxes has changed by -$305.18M (-155.15%)
What is Denali Therapeutics Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of DNLI is -$134.96M
What is the all-time high quarterly EBIT for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly earnings before interest & taxes is $244.08M
What is Denali Therapeutics Inc. quarterly EBIT year-on-year change?
Over the past year, DNLI quarterly earnings before interest & taxes has changed by -$18.37M (-15.76%)
What is Denali Therapeutics Inc. TTM earnings before interest & taxes?
The current TTM EBIT of DNLI is -$533.58M
What is the all-time high TTM EBIT for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high TTM earnings before interest & taxes is $62.72M
What is Denali Therapeutics Inc. TTM EBIT year-on-year change?
Over the past year, DNLI TTM earnings before interest & taxes has changed by -$38.36M (-7.75%)